Industry News
2015 Prime Minister's Prizes for Science announced
The 2015 Prime Minister's Prizes for Science were awarded on 21 October at a celebratory dinner held at Parliament House. [ + ]
A mini DNA sequencer
Oxford Nanopore Technologies has developed the MinION, a handheld device that works by detecting individual DNA bases that pass through a nanopore. [ + ]
Redefining temperature
Australian scientists have contributed to the worldwide effort of redefining the international unit of temperature: the kelvin. [ + ]
Could an arthritis drug slow diabetes development in children?
JDRF has announced a new clinical trial to slow the development of newly diagnosed type 1 diabetes in children. The trial will test a new application of an existing drug currently approved for use in children with juvenile arthritis. [ + ]
Revisiting 'The Dress'
Months after the phenomenon known as 'The Dress' hit the internet, neuroscientists have demonstrated that the optical illusion is linked to specific brain activation patterns. [ + ]
Olympus MD calls for focus on customer service
The managing director of Olympus Australia and New Zealand, James Bowe, has made his vision for the company clear, claiming that success is driven by customer relationships. [ + ]
A rebranding and a new CEO for Merck
Pharmaceutical company Merck has announced a relaunch of its brand identity in order to reflect its transformation into a global science and technology company. [ + ]
Prescient MD resigns
Dr Robert Crombie, the managing director of oncology company Prescient Therapeutics, has resigned in order to focus on other business opportunities. [ + ]
ASCVD drug trial terminated due to insufficient efficacy
Eli Lilly and Company (Lilly) will terminate its phase 3 trial of the investigational medicine evacetrapib due to insufficient efficacy. [ + ]
Promega multiplex assay approved by FBI
Promega's PowerPlex Fusion 6C System has been granted approval by the FBI in the United States for use in laboratories that generate DNA records for the National DNA Index System (NDIS). [ + ]
Cynata collaborates on cell therapy for cancer
Cynata Therapeutics will collaborate with Massachusetts General Hospital on the development of modified mesenchymal stem cells (MSCs) to treat cancer. [ + ]
Algae cultivation for biokerosene production
The Technical University of Munich has built a technical facility for algae cultivation at its Ludwig Bölkow Campus in Ottobrunn, south of Munich. The facility will develop efficient processes for producing biokerosene and chemical products from algae. [ + ]
Myelin researcher scores AbbVie Student Poster Award
The 2015 AbbVie Student Poster Awards recognised the important research being carried out by Australian graduate students in areas such as pharmaceutical sciences, disease research, biology and nutritional science. [ + ]
Starving breast cancer cells of nutrients
A research team led by Sydney's Centenary Institute has discovered a significant link between breast cancer and nutrition — one which could lead to a new treatment aimed at 'starving' breast cancer cells. [ + ]
ResMed completes Curative Medical acquisition
ResMed has completed its acquisition of Curative Medical, a provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories to the Chinese market. [ + ]

